These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4251631)

  • 21. Isoelectric focusing of human plasminogen, plasmin, and derived heavy (A) and light (B) chains.
    Robbins KC; Summaria L
    Ann N Y Acad Sci; 1973 Jun; 209():397-404. PubMed ID: 4268482
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of endogenous fibrinolysis activation on human plasminogen].
    Platonova TK; Kalashnikov VV; Khvatov VB
    Biull Eksp Biol Med; 1987 Jan; 103(1):59-61. PubMed ID: 2432967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasma.
    Müllertz S
    Scand J Clin Lab Invest; 1972 Dec; 30(4):369-79. PubMed ID: 4118172
    [No Abstract]   [Full Text] [Related]  

  • 24. Proteins of the human prostate tissue as characterized by electrophoresis, immunodiffusion and immunoelectrophoresis in agar gel, combined with histochemical staining methods.
    Mattila S
    Ann Chir Gynaecol Fenn; 1967; 56():1-29. PubMed ID: 4166200
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and properties of an antiactivator fraction from bovine serum.
    Nanninga LB; Guest MM
    Thromb Haemost; 1979 Oct; 42(3):855-63. PubMed ID: 92070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial purification of a specific plasminogen activator from porcine parotid glands.
    Cartwright T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):403-14. PubMed ID: 4420961
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preparation and properties of horse alpha2-macroglobulin].
    Lavergne M; Raynaud M
    Ann Inst Pasteur (Paris); 1970 Jul; 119(1):27-49. PubMed ID: 4988948
    [No Abstract]   [Full Text] [Related]  

  • 28. A low molecular weight antiplasmin of human blood platelets.
    Ganguly P
    Clin Chim Acta; 1972 Jul; 39(2):466-8. PubMed ID: 4625471
    [No Abstract]   [Full Text] [Related]  

  • 29. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
    Pechet L; Smith JA
    Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
    [No Abstract]   [Full Text] [Related]  

  • 30. [Euglobulin lysis time method (author's transl)].
    Kazama M
    Rinsho Byori; 1976 Apr; 24(4):316-20. PubMed ID: 132550
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum.
    Mui PT; James HL; Ganguly P
    Br J Haematol; 1975 Apr; 29(4):627-37. PubMed ID: 127607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behavior of the fibrinolytic factors during preservation of blood transfusion material].
    Dallavalle L; Colla G
    Riv Emoter Immunoematol; 1965; 12(5):119-31. PubMed ID: 4223985
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 34. [A quick photometric method for the determination of activable plasminogen and of plasmin].
    Bouvier CA; Berthoud S; Roth M
    Thromb Diath Haemorrh; 1967 May; 17(3-4):452-66. PubMed ID: 4231950
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in the immunochemical properties of highly purified properdin in human serum.
    Minta JO
    J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiactivator (antikinase) activity of human plasma and its blocking by parachloromercuribenzoate and salicylate.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1971 Dec; 26(3):541-56. PubMed ID: 4259444
    [No Abstract]   [Full Text] [Related]  

  • 37. Diffusion characteristics of human plasminogen (as shown by two agar diffusion techniques).
    Stuckey RJ; Wolf P
    Thromb Diath Haemorrh; 1969 Nov; 22(2):240-50. PubMed ID: 4191484
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of plasminogen in human blood plasma].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1974 May; 20(3):325-8. PubMed ID: 4275938
    [No Abstract]   [Full Text] [Related]  

  • 39. GEL FILTRATION OF FIBRINOLYTIC COMPONENTS OF BLOOD PLASMA IN MAN AND RABBIT.
    TAKADA A; TAKADA Y; OKAMOTO U
    Keio J Med; 1965 Mar; 14():37-43. PubMed ID: 14325515
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification and characterization of procoagulant in human urine.
    Matsuda M; Aoki N
    Thromb Res; 1978 Sep; 13(3):311-24. PubMed ID: 741428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.